Inactive Instrument

Company HINTO Energy, Inc. Other OTC

Equities

HENI

US4334751009

Investment Holding Companies

Business Summary

Hinto Energy, Inc., through its rights in JF BioPharma, Inc., is a developer of synthetic late stage schedule1 drugs. The Company’s focus is on synthetic cannabinoids to treat fibromyalgia, wound care, Type 2 diabetes and cystic fibrosis (CF).

Managers

Managers TitleAgeSince
Chief Executive Officer - 08/23/08
Chief Operating Officer - 07/23/07
Chief Tech/Sci/R&D Officer 68 07/23/07
Corporate Officer/Principal - 07/23/07

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer - 08/23/08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 43,040,000 22,770,000 ( 52.90 %) 0 52.90 %

Company contact information

Hinto Energy, Inc.

3 Bethesda Metro Suite 700

20814, Bethesda

+

address HINTO Energy, Inc.(HENI)